Concepedia

Publication | Open Access

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)

DOIFull Paper Access

220

Citations

39

References

2006

Year

R. P A Manzano, Gholam A. Peyman, Palwasha Khan, Petros Carvounis, M. Kivilcim, Min Ren, Jonathan Lake, Patricia Chévez‐Barrios
British Journal of Ophthalmology

Abstract

Topically administered bevacizumab (Avastin) at a concentration of 4 mg/ml limits corneal neovascularisation following chemical injury in the male Long Evans rat model.

References

YearCitations

Page 1